NATURALANTIBODY

NaturalAntibody was founded by Konrad Krawczyk, who spent the last decade researching computational approaches for enhancing the design of antibody-based therapeutics. The collaborations with leading academic institutions and pharmaceutical companies opened his eyes to the value of antibody data. Researchers can use this data to create advanced computational models promising to accelerate therapeutic antibody design and drug discovery processes... NaturalAntibody is an artificial intelligence-based platform that allows in silico discovery and design of antibodies. It combines the comprehensive Antibody Database with Antibody Analytics for predicting antibody characteristics such as immunogenicity, mutability, and developability. Using the Platform, you can quickly check if a given sequence was observed in any of the covered databases, find a similar sequence with legal protection, or leverage antibody data for predictive tasks such as mapping the mutational diversity, immunogenicity..

Also known as: NATURALANTIBODY S.A.